Portal de noticias > noticias

Obesity, heart disease, and diabetes may be communicable diseases


Non-communicable diseases such as heart disease, cancer and lung disease are the most common causes of death, accounting for 70 percent of deaths worldwide, and are considered ‘non-communicable’ because they are thought to be caused by a combination of genetic, lifestyle and environmental factors and cannot be transmitted between people. However, research by the Canadian Institute For Advanced Research’s (CIFAR) Humans and the Microbiome programme throws this long-held belief into question by providing evidence that many diseases may be transmissible between people through microbes (including bacteria, fungi and viruses) that live in and on our bodies.

"If our hypothesis is proven correct, it will rewrite the entire book on public health" said Dr B Brett Finlay, CIFAR Fellow and professor of microbiology at the University of British Columbia, who is lead author on the paper, ‘Are noncommunicable diseases communicable?’, published in the journal Science.

The authors base their hypothesis on connections between three distinct lines of evidence. First, they demonstrate that people with a wide range of conditions, from obesity and inflammatory bowel disease to type 2 diabetes and cardiovascular disease, have altered microbiomes. Next, they show that altered microbiomes, when taken from diseased people and put into animal models, cause disease. Finally, they provide evidence that the microbiome is naturally transmissible, for example, spouses who share a house have more similar microbiomes than twins who live separately.

"When you put those facts together, it points to the idea that many traditionally non-communicable diseases may be communicable after all," added Finlay.

Eran Elinav, an author on the paper, CIFAR fellow, and professor at the Weizmann Institute of Science, sees the proposed connection between these points of evidence as an argument for thinking about disease more broadly: "This may represent new opportunities for interventions in some of the world's most common and bothersome diseases. We can now think about modulating environmental factors and the microbiome, not just about targeting the human host."

"This paper provides a provocative new way to think about non-communicable diseases, with important implications for public health," explained Alan Bernstein, President and CEO of CIFAR. "Ideas like this are a great example of what happens when top researchers from around the world work together in an environment of trust, transparency, and knowledge sharing."

The authors added that the paper was a direct result of open and exploratory discussions at a CIFAR program meeting in March 2019.

"The idea developed from the integration of emerging biological data from animal models and from humans, coupled with critical insights with partners dealing with the same concepts, in other contexts, in anthropology and social sciences," said Elinav.

"It started as a thought experiment," explained Finlay. "But then there was huge excitement when we started thinking about what there was evidence for. As the paper started coming together and new pieces of evidence from different specialties came in, discussions were flying around the table."

While there is a lot of excitement about this hypothesis, the researchers are clear that much remains unknown about the mechanisms involved. "We still don't know in what cases transmission increases, or whether healthy outcomes can also be transmitted," added Dr Maria Gloria Dominguez-Bello, an author on the paper, CIFAR fellow, and professor at Rutgers University. "We need more research to understand microbial transmission and its effects."

"We hope the paper will inspire further research into the mechanisms and extent of communicability." concluded Finlay. "We encourage researchers studying any disease to think about what effect microbes may be having."

CIFAR's Humans & the Microbiome program benefits from its international, interdisciplinary network of fellows, advisors and CIFAR Azrieli Global Scholars that includes microbiologists, anthropologists, immunologists, and geneticists, among others. Together they are discovering how microbes that live in and on us affect our health, development and even behaviour.

Últimas noticias
Arriba Volver Atrás
 C/ Castelló 128 - 7º 28006 Madrid - SPAIN
Mapa web Aviso legal Política de Cookies

Bienvenida/o a la información básica sobre las cookies de la página web responsabilidad de la entidad: Sociedad Española de Cirugía de la Obesidad y Enfermedades Metabólicas

Una cookie o galleta informática es un pequeño archivo de información que se guarda en tu ordenador, “smartphone” o tableta cada vez que visitas nuestra página web. Algunas cookies son nuestras y otras pertenecen a empresas externas que prestan servicios para nuestra página web.

Las cookies pueden ser de varios tipos: las cookies técnicas son necesarias para que nuestra página web pueda funcionar, no necesitan de tu autorización y son las únicas que tenemos activadas por defecto.

El resto de cookies sirven para mejorar nuestra página, para personalizarla en base a tus preferencias, o para poder mostrarte publicidad ajustada a tus búsquedas, gustos e intereses personales. Puedes aceptar todas estas cookies pulsando el botón ACEPTA TODO o configurarlas o rechazar su uso clicando en el apartado CONFIGURACIÓN DE COOKIES.

Si quires más información, consulta la POLITICA COOKIES de nuestra página web.